Manage Tickers Link Financial Account

Has my stock been accused of fraud?Join over 160k users who know.

Ticker	Price	Change($)	Change(%)	Shares	Volume	Prev Close	Open	Gain($)	Gain(%)

Ticker	Status	Jurisdiction	Filing Date	CP Start	CP End	CP Loss	Deadline

Ticker	Case Name	Status	CP Start	CP End	Deadline	Settlement Amt

Ticker	Name	Date	Analyst Firm	Up/Down	Target ($)	Rating Change	Rating Current

Maxim Group Maintains Buy on Anebulo Pharmaceuticals, Lowers Price Target to $3

Author: Benzinga Newsdesk | May 15, 2025 01:14pm

Maxim Group analyst Michael Okunewitch maintains Anebulo Pharmaceuticals (NASDAQ:ANEB) with a Buy and lowers the price target from $6 to $3.

Posted In: ANEB